These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2007843)
41. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. O'Riordan S; Ouldred E; Brice S; Jackson SH; Swift CG Br J Clin Pharmacol; 2002 Apr; 53(4):398-402. PubMed ID: 11966673 [TBL] [Abstract][Full Text] [Related]
42. Effects of renal function on plasma digoxin levels in elderly ambulant patients in domiciliary practice. Baylis EM; Hall MS; Lewis G; Marks V Br Med J; 1972 Feb; 1(5796):338-41. PubMed ID: 5008659 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetic design of digoxin dosage regimens in relation to renal function. Jusko WJ; Szefler SJ; Goldfarb AL J Clin Pharmacol; 1974 Oct; 14(10):525-35. PubMed ID: 4430731 [No Abstract] [Full Text] [Related]
44. Digitalis pharmacokinetics and metabolism. Marcus FI Am J Med; 1975 Apr; 58(4):452-9. PubMed ID: 1092160 [TBL] [Abstract][Full Text] [Related]
45. Diltiazem increases steady state digoxin serum levels in patients with cardiac disease. Andrejak M; Hary L; Andrejak MT; Lesbre JP J Clin Pharmacol; 1987 Dec; 27(12):967-70. PubMed ID: 3437068 [TBL] [Abstract][Full Text] [Related]
47. Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment. Jogestrand T; Ericsson F; Sundqvist K Eur J Clin Pharmacol; 1981 Jan; 19(2):97-105. PubMed ID: 7202477 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of digoxin-specific Fab: effects of decreased renal function and age. Renard C; Grene-Lerouge N; Beau N; Baud F; Scherrmann JM Br J Clin Pharmacol; 1997 Aug; 44(2):135-8. PubMed ID: 9278197 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction. Schenck-Gustafsson K; Dahlqvist R Br J Clin Pharmacol; 1981 Feb; 11(2):181-6. PubMed ID: 7213521 [TBL] [Abstract][Full Text] [Related]
50. Dose-independent pharmacokinetics of digoxin in humans. Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of two prediction models for digoxin dosing. Markantonis SL; Kyroudis A; Christopoulos T Pharm World Sci; 1993 Feb; 15(1):29-33. PubMed ID: 8485504 [TBL] [Abstract][Full Text] [Related]
52. Clinical pharmacokinetics of digoxin. Iisalo E Clin Pharmacokinet; 1977; 2(1):1-16. PubMed ID: 322907 [TBL] [Abstract][Full Text] [Related]
53. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. Yukawa E; Mine H; Higuchi S; Aoyama T J Pharm Pharmacol; 1992 Sep; 44(9):761-5. PubMed ID: 1360530 [TBL] [Abstract][Full Text] [Related]
54. Digitalisation and digitalis detoxication in the elderly. Caird FI; Kennedy RD Age Ageing; 1977 Feb; 6(1):21-8. PubMed ID: 842402 [TBL] [Abstract][Full Text] [Related]
55. Effects of compensated heart failure on digoxin pharmacokinetics in cats. Atkins CE; Snyder PS; Keene BW; Rush JE J Am Vet Med Assoc; 1989 Oct; 195(7):945-50. PubMed ID: 2793576 [TBL] [Abstract][Full Text] [Related]
56. The effect of captopril on pharmacokinetics of digoxin in patients with mild congestive heart failure. Miyakawa T; Shionoiri H; Takasaki I; Kobayashi K; Ishii M J Cardiovasc Pharmacol; 1991 Apr; 17(4):576-80. PubMed ID: 1711623 [TBL] [Abstract][Full Text] [Related]
57. A score for prescribing digoxin. Nicholson PW; Dobbs SM; McGill AP; Rodgers EM; Slater E Br Heart J; 1978 Feb; 40(2):177-83. PubMed ID: 637967 [TBL] [Abstract][Full Text] [Related]